MENU
Home
Add Document
Sign In
Create An Account
PDF Reader
Full Text
700
(0.9 g/1), but rose slowly to normal by day 10. The plasma-viscosity was reduced by 12% during ancrod treatment (P
Suggest Documents
Preservation of renal function in chronic renal failure.
Reversible renal failure during treatment with captopril.
Reversible renal failure during treatment with captopril.
Reversible renal failure during treatment with captopril.
Facilities for treatment of chronic renal failure.
Foregut motor function in chronic renal failure.
Left ventricular function in chronic renal failure.
Renal function during erythropoietin therapy for anemia in predialysis chronic renal failure patients.
Renal cell carcinoma in chronic renal failure without dialysis treatment.
Sweating treatment for chronic renal failure.
The Prognostic Importance of Changes in Renal Function during Treatment for Acute Heart Failure Depends on Admission Renal Function.
Gastric function in chronic renal failure. Effects of maintenance haemodialysis.
Management of chronic renal failure.
Chronic renal failure: management.
Renal tolerance for ioxaglate in patients with chronic renal failure.
Chronic renal failure: pathophysiology.
Management of chronic renal failure.
Reversible Deterioration in Hypophosphatasia Caused by Renal Failure With Bisphosphonate Treatment.
Bone mineral content in chronic renal failure during long-term treatment with 1alpha-hydroxycholecalciferol.
Development of chronic heart failure in a young woman with hypertension associated with renal artery stenosis with preserved renal function.
The metabolic acidosis of chronic renal failure: pathophysiology and treatment.
Parathyroidectomy Halts the Deterioration of Renal Function in Primary Hyperparathyroidism.
Tubular damage and worsening renal function in chronic heart failure.
Impact of chronic renal failure on anti-tuberculosis treatment outcomes.
Deterioration of renal function during treatment of chronic renal failure with 1,25-dihydroxycholecalciferol.
700 (0.9 g/1), but rose slowly to normal by day 10. The plasma-viscosity was reduced by 12% during ancrod treatment (P...
523KB Sizes
0 Downloads
0 Views
Download PDF
Recommend Documents
Preservation of renal function in chronic renal failure.
Reversible renal failure during treatment with captopril.
Reversible renal failure during treatment with captopril.
Reversible renal failure during treatment with captopril.
Facilities for treatment of chronic renal failure.
Foregut motor function in chronic renal failure.
Left ventricular function in chronic renal failure.
Renal function during erythropoietin therapy for anemia in predialysis chronic renal failure patients.
Renal cell carcinoma in chronic renal failure without dialysis treatment.
Sweating treatment for chronic renal failure.
×
Sign In
Login with Facebook
Don't have an account?
Forgot Password?
×
Sign Up
By clicking register, I agree to your terms
